Setting New Safety Standards in Interventional Imaging

Reducing radiation exposure while maintaining image quality and workflow isn’t just a goal, it should be the gold standard for interventionalists. Yet, most X-ray manufacturers have failed to embrace Region of Interest (ROI) technology, leaving physicians and technicians without the best tools to prioritize safety.

Studies confirm ROI technology’s ability to dramatically reduce radiation dose outside the region of interest, but adoption remains limited. Radiation exposure continues to pose significant risks in interventional labs – impacting physicians, staff, and patients. While ALARA (as low as reasonably achievable) provides a baseline for safety, shouldn’t we strive for something greater?

Omega is leading the way by offering systems that significantly reduce dose-area product radiation exposure through proprietary secondary collimation technology. Designed with adaptability in mind, our systems empower users to choose manual, automatic, or off modes and are tailored to individual needs and preferences.

As the only FDA-cleared interventional system integrating ROI and AI technology, Omega is setting a new benchmark in safety and performance.

The question is, why settle for outdated standards when a proven, life-saving alternative is available?

Omega’s systems go beyond managing risks, they’re about creating a safer, smarter future. Our technology ensures unparalleled protection while maintaining seamless workflow integration and delivering superior image quality.

Discover how Omega’s solutions redefine interventional imaging at OmegaMedicalImaging.com.